Company DNA
Performance-Driven
About
Star Health Insu is a Large Cap company in the Financial Services sector, listed on NSE as STARHEALTH. With a market cap of ₹26K Cr and revenue of ₹16K Cr, it is currently in the High Growth phase. Known for its Performance-Driven culture and Disruptor approach to innovation, the company operates at a Startup-Speed pace. Aggressive sales-led growth culture common in private insurance, focused on rapid market share expansion and high-target tracking. Its strategic mandate: Requires improved claims management and cost-to-income optimization to sustain market leadership amidst rising healthcare costs.
FAQ
What kind of company is Star Health Insu?
Star Health Insu is a Large Cap Financial Services company (STARHEALTH) in the High Growth phase with a market cap of ₹26K Cr. It is classified as Performance-Driven in culture.
What is Star Health Insu's culture and work environment like?
Star Health Insu has a Performance-Driven culture with Disruptor innovation DNA and a Startup-Speed pace of execution. Employee brand: Demanding Machine. Customer relationship style: Mass-Consumer. Aggressive sales-led growth culture common in private insurance, focused on rapid market share expansion and high-target tracking.
Who leads Star Health Insu?
Star Health Insu is led by Anand Roy (Managing Director & CEO), a Transformational leader with 25 years of experience.
What are Star Health Insu's financials?
Star Health Insu reported revenue of ₹16K Cr in FY25 with a 5-year revenue CAGR of 15.9%. Operating margin: —. Market cap: ₹26K Cr.
Culture & Strategy
CulturePerformance-Driven
InnovationDisruptor
PaceStartup-Speed
PurposeMission-First
CustomerMass-Consumer
EmployeeDemanding Machine
BrandValue-Champion
LifecycleHigh Growth
Aggressive sales-led growth culture common in private insurance, focused on rapid market share expansion and high-target tracking.
Mandate
Requires improved claims management and cost-to-income optimization to sustain market leadership amidst rising healthcare costs.
Requires improved claims management and cost-to-income optimization to sustain market leadership amidst rising healthcare costs.
Financials
Revenue FY25₹16K Cr
PAT FY25₹646 Cr
Rev CAGR 5Y15.9%
OPM—
NPM3.9%
ROE9.1%
ROCE—
P/E61
Fwd P/E29.4
P/B3.6
D/E6.2
Mkt Cap₹26K Cr
Promoter63.1%
Institutional24.2%
Similar Culture
Could You Lead Star Health Insu?
Take the Genome Benchmark →